# Eribulin

## Halaven inj 1mg/2mL

##### 

| TAH Drug Code      | IHALA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treatment of Breast cancer, metastatic.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Dosing             | 1.4 mg/m2 on days 1 and 8 of a 21-day treatment cycle until disease progression or unacceptable toxicity.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Contraindications  | Hypersensitivity to eribulin mesylate, halichondrin B, or its chemical derivatives.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Adverse Effects    | >10%: Central nervous system: Fatigue (54%), fever (21%), headache (19%) Dermatologic: Alopecia (45%) Gastrointestinal: Nausea (35%), constipation (25%), weight loss (21%), anorexia (20%), diarrhea (18%), stomatitis (5% to 18%), vomiting (18%) Hematologic: Neutropenia (82%; grades 3: 28%; grade 4: 29%; nadir: 13 days; recovery: 8 days), anemia (58%; grades 3/4: 2%) Hepatic: ALT increased (18%) Neuromuscular & skeletal: Weakness (54%), peripheral neuropathy (35%; grades 3/4: ?8%), arthralgia/myalgia (22%), back pain (16%), bone pain (12%), limb pain (11%) Respiratory: Dyspnea (16%), cough (14%) 1% to 10%: Cardiovascular: Peripheral edema Central nervous system: Depression, dizziness, insomnia Dermatologic: Rash Endocrine & metabolic: Hypokalemia Gastrointestinal: Mucosal inflammation (9%), abdominal pain, dyspepsia, taste alteration, xerostomia Genitourinary: Urinary tract infection (10%) Hematologic: Neutropenic fever (5%), thrombocytopenia (grades 3/4: 1%) Neuromuscular & skeletal: Muscle spasm Ocular: Lacrimation increased Respiratory: Upper respiratory infection <1% (Limited to important or life-threatening): Pancreatitis, pharyngolaryngeal pain, sepsis |
| Pregnancy          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Lactation          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |

